XML 41 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2
Segment Reporting (Tables)
 9 Months Ended
Sep. 30, 2016
Segment Reporting [Abstract]  
Reconciliation of the Company's business segments to the consolidated financial statements
In millions
Pharmacy
Services
Segment(1)
 
Retail/LTC
Segment
 
Corporate
Segment
 
Intersegment
Eliminations(2)
 
Consolidated
Totals
Three Months Ended
 
 
 
 
 
 
 
 
 
September 30, 2016:
 
 
 
 
 
 
 
 
 
Net revenues
$
30,429

 
$
20,143

 
$
—

 
$
(5,957
)
 
$
44,615

Gross profit(3)
1,797

 
5,893

 
—

 
(198
)
 
7,492

Operating profit (loss)(4)(5)
1,458

 
1,773

 
(229
)
 
(185
)
 
2,817

September 30, 2015:
 

 
 

 
 

 
 

 
 

Net revenues
25,528

 
17,912

 
—

 
(4,796
)
 
38,644

Gross profit
1,468

 
5,373

 
—

 
(180
)
 
6,661

Operating profit (loss)(4)(5)
1,162

 
1,643

 
(309
)
 
(165
)
 
2,331

Nine Months Ended
 

 
 

 
 

 
 

 
 

September 30, 2016:
 

 
 

 
 

 
 

 
 

Net revenues
88,704

 
60,253

 
—

 
(17,402
)
 
131,555

Gross profit(3)
4,266

 
17,560

 
—

 
(575
)
 
21,251

Operating profit (loss)(4)(5)
3,278

 
5,255

 
(661
)
 
(529
)
 
7,343

September 30, 2015:
 

 
 

 
 

 
 

 
 

Net revenues
73,849

 
52,105

 
—

 
(13,810
)
 
112,144

Gross profit
3,735

 
15,990

 
—

 
(498
)
 
19,227

Operating profit (loss)(4)(5)
2,837

 
5,050

 
(712
)
 
(450
)
 
6,725


(1) 
Net revenues of the Pharmacy Services Segment include approximately $2.5 billion and $2.1 billion of retail co-payments for the three months ended September 30, 2016 and 2015, respectively, as well as $8.1 billion and $6.8 billion of retail co-payments for the nine months ended September 30, 2016 and 2015, respectively.
(2)
Intersegment eliminations relate to intersegment revenue generating activities that occur between the Pharmacy Services Segment and the Retail/LTC Segment. These occur in the following ways: when members of Pharmacy Services Segment clients (“members”) fill prescriptions at the Company's retail stores to purchase covered products, when members enrolled in programs such as Maintenance Choice ® elect to pick up maintenance prescriptions at one of the Company's retail stores instead of receiving them through the mail, or when members have prescriptions filled at the Company's long-term care pharmacies. When these occur, both the Pharmacy Services and Retail/LTC segments record the revenues, gross profit and operating profit on a standalone basis.
(3)
The Retail/LTC Segment gross profit for the three and nine months ended September 30, 2016 includes $5 million and $15 million, respectively, of acquisition-related integration costs. The integration costs are related to the acquisitions of Omnicare and the pharmacies and clinics of Target.
(4)
The Retail/LTC Segment operating profit for the three and nine months ended September 30, 2016 includes $52 million and $194 million, respectively, of acquisition-related integration costs. The Retail/LTC Segment operating profit for the three and nine months ended September 30, 2015 includes $12 million of acquisition-related integration costs. The integration costs are related to the acquisitions of Omnicare and the pharmacies and clinics of Target.
(5)
The Corporate Segment operating loss for the three and nine months ended September 30, 2016 includes $13 million of integration costs. The Corporate Segment operating loss for the three and nine months ended September 30, 2015 includes $115 million and $135 million, respectively, of acquisition-related transaction and integration costs.